N.Y. Cannabis Law Section 3
Definitions


Whenever used in this chapter, unless otherwise expressly stated or unless the context or subject matter requires a different meaning, the following terms shall have the representative meanings hereinafter set forth or indicated:

1.

“Applicant” unless otherwise specified in this chapter, shall mean a person applying for any cannabis, medical cannabis or cannabinoid hemp license or permit issued by the New York state cannabis control board pursuant to this chapter that: has a significant presence in New York state, either individually or by having a principal corporate location in the state; is incorporated or otherwise organized under the laws of this state; or a majority of the ownership are residents of this state. For the purposes of this subdivision, “person” means an individual, institution, corporation, government or governmental subdivision or agency, business trust, estate, trust, partnership or association, or any other legal entity.

2.

“Cannabinoid” means the phytocannabinoids found in hemp and does not include synthetic cannabinoids as that term is defined in subdivision (g) of schedule I of Public Health Law § 3306 (Schedules of controlled substances)section thirty-three hundred six of the public health law.

3.

“Cannabinoid hemp” means any hemp and any product processed or derived from hemp, that is used for human consumption provided that when such product is packaged or offered for retail sale to a consumer, it shall not have a concentration of more than three tenths of a percent delta-9 tetrahydrocannabinol.

4.

“Cannabinoid hemp processor license” means a license granted by the office to process, extract, pack or manufacture cannabinoid hemp or hemp extract into products, whether in intermediate or final form, used for human consumption.

5.

“Cannabis” means all parts of the plant of the genus Cannabis, whether growing or not; the seeds thereof; the resin extracted from any part of the plant; and every compound, manufacture, salt, derivative, mixture, or preparation of the plant, its seeds or resin. It does not include the mature stalks of the plant, fiber produced from the stalks, oil or cake made from the seeds of the plant, any other compound, manufacture, salt, derivative, mixture, or preparation of the mature stalks (except the resin extracted therefrom), fiber, oil, or cake, or the sterilized seed of the plant which is incapable of germination. It does not include hemp, cannabinoid hemp or hemp extract as defined by this section or any drug products approved by the federal Food and Drug Administration.

6.

“Cannabis consumer” means a person twenty-one years of age or older acting in accordance with any provision of this chapter.

7.

“Cannabis control board” or “board” means the New York state cannabis control board created pursuant to article 2 (New York State Cannabis Control Board)article two of this chapter.

8.

“Cannabis flower” means the flower of a plant of the genus Cannabis that has been harvested, dried, and cured, prior to any processing whereby the plant material is transformed into a concentrate, including, but not limited to, concentrated cannabis, or an edible or topical product containing cannabis or concentrated cannabis and other ingredients. Cannabis flower excludes leaves and stem.

9.

“Cannabis product” or “adult-use cannabis product” means cannabis, concentrated cannabis, and cannabis-infused products for use by a cannabis consumer.

10.

“Cannabis-infused products” means products that have been manufactured and contain either cannabis or concentrated cannabis and other ingredients that are intended for use or consumption.

11.

“Cannabis trim” means all parts of the plant of the genus Cannabis other than cannabis flower that have been harvested, dried, and cured, but prior to any further processing.

12.

“Caring for” means treating a patient, in the course of which the practitioner has completed a full assessment of the patient’s medical history and current medical condition.

13.

“Certification” means a certification made under this chapter.

14.

“Certified medical use” includes the acquisition, cultivation, manufacture, delivery, harvest, possession, preparation, transfer, transportation, or use of medical cannabis for a certified patient, or the acquisition, administration, cultivation, manufacture, delivery, harvest, possession, preparation, transfer, or transportation of medical cannabis by a designated caregiver or designated caregiver facility, or paraphernalia relating to the administration of cannabis, including whole cannabis flower, to treat or alleviate a certified patient’s medical condition or symptoms associated with the patient’s medical condition.

15.

“Certified patient” means a patient who is a resident of New York state or receiving care and treatment in New York state as determined by the board in regulation, and is certified under this chapter.

16.

“Chief equity officer” means the chief equity officer of the office of cannabis management.

17.

“Concentrated cannabis” means:

(a)

the separated resin, whether crude or purified, obtained from cannabis; or

(b)

a material, preparation, mixture, compound or other substance which contains more than three percent by weight or by volume of total THC, as defined in this section.

18.

“Condition” means having one of the following conditions: cancer, positive status for human immunodeficiency virus or acquired immune deficiency syndrome, amyotrophic lateral sclerosis, Parkinson’s disease, multiple sclerosis, damage to the nervous tissue of the spinal cord with objective neurological indication of intractable spasticity, epilepsy, inflammatory bowel disease, neuropathies, Huntington’s disease, post-traumatic stress disorder, pain that degrades health and functional capability where the use of medical cannabis is an alternative to opioid use, substance use disorder, Alzheimer’s, muscular dystrophy, dystonia, rheumatoid arthritis, autism or any other condition certified by the practitioner.

19.

“Cultivation” means growing, cloning, harvesting, drying, curing, grading, and trimming of cannabis plants for sale to certain other categories of cannabis license- and permit-holders.

20.

“Delivery” means the direct delivery of cannabis products by a retail licensee, microbusiness licensee, or delivery licensee to a cannabis consumer.

21.

“Designated caregiver facility” means a facility that registers with the office to assist one or more certified patients with the acquisition, possession, delivery, transportation or administration of medical cannabis and is a: general hospital or residential health care facility operating pursuant to article twenty-eight of the public health law; an adult care facility operating pursuant to title two of article seven of the social services law; a community mental health residence established pursuant to section 41.44 of the mental hygiene law; a hospital operating pursuant to section 7.17 of the mental hygiene law; a mental hygiene facility operating pursuant to article thirty-one of the mental hygiene law; an inpatient or residential treatment program certified pursuant to article thirty-two of the mental hygiene law; a residential facility for the care and treatment of persons with developmental disabilities operating pursuant to article sixteen of the mental hygiene law; a residential treatment facility for children and youth operating pursuant to article thirty-one of the mental hygiene law; a private or public school; research institution with an internal review board; or any other facility as determined by the board in regulation.

22.

“Designated caregiver” means an individual designated by a certified patient in a registry application. A certified patient may designate up to five designated caregivers not counting designated caregiver facilities or designated caregiver facilities’ employees.

23.

“Designated caregiver facility employee” means an employee of a designated caregiver facility.

24.

“Distributor” means any person who sells at wholesale any cannabis product, except medical cannabis, for the sale of which a license is required under the provisions of this chapter.

25.

“Executive director” means the executive director of the office of cannabis management.

26.

“Form of medical cannabis” means characteristics of the medical cannabis recommended or limited for a particular certified patient, including the method of consumption and any particular strain, variety, and quantity or percentage of cannabis or particular active ingredient, or whole cannabis flower.

27.

“Hemp” means the plant Cannabis sativa L. and any part of such plant, including the seeds thereof and all derivatives, extracts, cannabinoids, isomers, acids, salts, and salts of isomers, whether growing or not, with a delta-9 tetrahydrocannabinol concentration (THC) of not more than three-tenths of a percent on a dry weight basis. It shall not include “medical cannabis” as defined in this section.

28.

“Hemp extract” means all derivatives, extracts, cannabinoids, isomers, acids, salts, and salts of isomers derived from hemp, used or intended for human consumption, for its cannabinoid content, with a delta-9 tetrahydrocannabinol concentration of not more than an amount determined by the office in regulation. For the purpose of this article, hemp extract excludes (a) any food, food ingredient or food additive that is generally recognized as safe pursuant to federal law; or

(b)

any hemp extract that is not used for human consumption. Such excluded substances shall not be regulated pursuant to the provisions of this article but are subject to other provisions of applicable state law, rules and regulations.

29.

“Labor peace agreement” means an agreement between an entity and a labor organization that, at a minimum, protects the state’s proprietary interests by prohibiting labor organizations and members from engaging in picketing, work stoppages, boycotts, and any other economic interference with the entity.

30.

“Laboratory testing facility” means any independent laboratory capable of testing cannabis and cannabis products for adult-use and medical-use; cannabinoid hemp and hemp extract; or for all categories of cannabis and cannabis products as per regulations set forth by the state cannabis control board.

31.

“License” means a written authorization as provided under this chapter permitting persons to engage in a specified activity authorized pursuant to this chapter.

32.

“Licensee” means an individual or an entity who has been granted a license under this chapter.

33.

“Medical cannabis” means cannabis as defined in this section, intended for a certified medical use, as determined by the board in consultation with the commissioner of health.

34.

“Microbusiness” means a licensee that may act as a cannabis producer for the cultivation of cannabis, a cannabis processor, a cannabis distributor and a cannabis retailer under this article; provided such licensee complies with all requirements imposed by this article on licensed producers, processors, distributors and retailers to the extent the licensee engages in such activities.

35.

“Nursery” means a licensee that produces only clones, immature plants, seeds, and other agricultural products used specifically for the planting, propagation, and cultivation of cannabis by licensed adult use cannabis cultivators, microbusinesses, cooperatives and registered organizations.

36.

“Office” or “office of cannabis management” means the New York state office of cannabis management.

37.

“On-site consumption” means the consumption of cannabis in an area licensed as provided for in this chapter.

38.

“Package” means any container or receptacle used for holding cannabis or cannabis products.

39.

“Permit” means a permit issued pursuant to this chapter.

40.

“Permittee” means any person to whom a permit has been issued pursuant to this chapter. 40-a. “Person” means an individual, institution, corporation, government or governmental subdivision or agency, business trust, estate, trust, partnership or association, or any other entity.

41.

“Practitioner” means a practitioner who is licensed, registered or certified by New York state to prescribe controlled substances within the state. Nothing in this chapter shall be interpreted so as to give any such person authority to act outside their scope of practice as defined by title eight of the education law. Additionally, nothing in this chapter shall be interpreted to allow any unlicensed, unregistered, or uncertified person to act in a manner that would require a license, registration, or certification pursuant to title eight of the education law.

42.

“Processor” means a licensee that extracts concentrated cannabis and/or compounds, blends, extracts, infuses, or otherwise manufactures concentrated cannabis or cannabis products, but not the cultivation of the cannabis contained in the cannabis product.

43.

“Registered organization” means an organization registered under article 3 (Medical Cannabis)article three of this chapter.

44.

“Registry application” means an application properly completed and filed with the board by a certified patient under article 3 (Medical Cannabis)article three of this chapter.

45.

“Registry identification card” means a document that identifies a certified patient or designated caregiver, as provided under this chapter.

46.

“Retail sale” means to solicit or receive an order for, to keep or expose for sale, and to keep with intent to sell, made by any licensed person, whether principal, proprietor, agent, or employee, of any cannabis, cannabis product, cannabinoid hemp or hemp extract product to a cannabis consumer for any purpose other than resale. 46-a. “Indirect retail sale” means to give any cannabis, cannabis product, cannabinoid hemp, hemp extract product, or any product marketed or labeled as such by any person engaging in a commercial business venture or otherwise providing or offering goods or services to the general public for remuneration for such goods and/or services, where any such cannabis, cannabis product, cannabinoid hemp or hemp extract product, or any product marketed or labeled as such, accompanies (a) the sale of any tangible or intangible property; or

(b)

the provision of any service, including but not limited to entry to a venue or event, or a benefit of a membership to a club, association, or other organization.

47.

“Retailer” means any person who sells at retail any cannabis product, the sale of which a license is required under the provisions of this chapter.

48.

“Small business” means small business as defined in Economic Development Law § 131 (Definition of a small business)section one hundred thirty-one of the economic development law, and shall apply for purposes of this chapter where any inconsistencies exist.

49.

“Smoking” means the burning of a lighted cigar, cigarette, pipe or any other matter or substance which contains cannabis including the use of an electronic smoking device that creates an aerosol or vapor.

50.

“Social and economic equity applicant” means an individual or an entity who is eligible for priority licensing pursuant to the criteria established in article 4 (Adult-use Cannabis)article four of this chapter.

51.

“Terminally ill” means an individual has a medical prognosis that the individual’s life expectancy is approximately one year or less if the illness runs its normal course.

52.

“THC” means Delta-9-tetrahydrocannabinol; Delta-8-tetrahydrocannabinol; Delta-10-tetrahydrocannabinol and the optical isomer of such substances.

53.

“Total THC” means the sum of the percentage by weight or volume measurement of tetrahydrocannabinolic acid multiplied by 0.877, plus, the percentage by weight or volume measurement of THC.

54.

“Warehouse” means and includes a place in which cannabis products are securely housed or stored.

55.

“Wholesale” means to solicit or receive an order for, to keep or expose for sale, and to keep with intent to sell, made by any licensed person, whether principal, proprietor, agent, or employee of any adult-use, medical-use cannabis or cannabis product, or cannabinoid hemp and hemp extract product for purposes of resale.

Source: Section 3 — Definitions, https://www.­nysenate.­gov/legislation/laws/CAN/3 (updated May 12, 2023; accessed Oct. 26, 2024).

Accessed:
Oct. 26, 2024

Last modified:
May 12, 2023

§ 3’s source at nysenate​.gov

Link Style